A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada for Pre-Exposure Prophylaxis (PrEP)

12/07/2018
02/07/2024
EU PAS number:
EUPAS24374
Study
Finalised
Documents
Study protocol
Initial protocol
English (422.38 KB - PDF) View document
Study results
Study results
English (3.7 MB - PDF) View document
Study report
Other information